Physical Exam, Static & Dynamic Ultrasound Assessment, & Treatment of Thoracolumbar Fascia (TLF) Mediated Low Back Pain
Machine Learning Analysis of Ultrasound Images for the Investigation of Thoracolumbar Myofascial Pain and Therapeutic Efficacy of Hydrodissection (DoD) and Osteopathic Manipulative Treatment (AOA) for Thoracolumbar Fascia Glide Impairment
1 other identifier
interventional
200
1 country
1
Brief Summary
This Study is for our continued study of the Thoracolumbar Fascia (TFL) in patients with and without low back pain by our experienced multidisciplinary team: Vincent Wang PhD, VT Biomedical Engineering \& Mechanics (BEAM). Albert J Kozar DO, FAOASM, R-MSK. P. Gunnar Brolinson, DO, FAOASM, FAOCFP. David T. Redden PhD, VCOM Research Biostatistician. Matthew Chung DO, VCOM and Team Physician at Virginia Tech. Edward Magalhaes, PhD, LPC, Psychiatry and Neuro- Behavioral Sciences, VCOM. This listing is specifically for our renewed efforts via two, Department of Defense (DoD) and American Osteopathic Association (AOA), extramurally, simultaneously funded grants for similar but distinct projects. Both funding sources are aware of each other's funding and have approved their grant study moving forward simultaneously with some integration. DoD: Machine Learning Analysis of Ultrasound Images for the Investigation of Thoracolumbar Myofascial Pain and Therapeutic Efficacy of Hydrodissection. The primary objectives of the proposed project are to:
- 1.develop reliable, quantitative image analysis approaches to objectively distinguish images from subjects with acute or chronic TLF pain from those without pain and
- 2.to assess the preliminary clinical efficacy of hydrodissection of the TLF as a novel therapeutic treatment for chronic LBP.
- 3.assess the preliminary clinical efficacy of OMT as a therapeutic treatment for CLBP of TLF origin and
- 4.develop reliable, quantitative image analysis approaches to objectively distinguish images from subjects with TLF pain from those without pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable low-back-pain
Started Sep 2023
Longer than P75 for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 28, 2024
CompletedFirst Posted
Study publicly available on registry
February 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 13, 2026
August 1, 2025
3.2 years
October 28, 2024
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Passive and Active motion induced TLF glide motion
Glide motion will be measured in mm. As Pilot Study, the lower 33rd percentile of motion will be considered glide impairment. Dynamic cine loops are obtained with 1. Five cycles of 20 degree prone trunk flexion (PTF) induced by a motorized table were recorded, with probe centered vertically over L3-L4 paraspinal muscles. 2. Five cycles of 12" prone active straight leg raise (pASLR), contralateral \& ipsilateral, were recorded with probe centered vertically over T12-L1 paraspinal muscles. Active glide has never been studied. the investigators will be looking at multiple properties of glide motion. In regards to AIM 3 treatment arms, after all 3 treatments of either hydrodisection or OMT, are completed: 1. Short term improvement will be assessed compared to baseline at 6 weeks. 2. Long Term improvement will be assessed compared to baseline at 24 weeks.
After AIM 3 treatment arms, after all 3 treatments of either hydrodisection or OMT, are completed: 1) Short term improvement will be assessed compared to baseline at 6 weeks. 2) Long Term improvement will be assessed compared to baseline at 24 weeks
Secondary Outcomes (3)
Physical Exam Maneuvers to Predict TLF involvement in Subjects with CLBP.
Positive tests will be determined at baseline. Resolution of positive tests after CLBP subject treatments will be assessed at 2 week followup scans.
SWE measurements in CLBP vs No LBP
At Baseline.
SWE measurements Post Treatments in CLBP Subjects
After AIM 3 treatment arms, after all 3 treatments of either hydrodisection or OMT, are completed: 1) Short term improvement will be assessed compared to baseline at 6 weeks. 2) Long Term improvement will be assessed compared to baseline at 24 weeks
Study Arms (2)
Ultrasound Guided Hydrodissection of TLF Glide Impairment
EXPERIMENTALCLBP Subjects with documented TLF glide impairment will undergo a series of 3 ultrasound-guided hydrodissection treatments of the TLF at 2-3 locations bilaterally, covering T11-S2, using D5w (132 cc total) and 22g 4" needle at 2-3 week intervals, using direct ultrasound guidance using a high frequency probe. Fluid pressure dissection/debridement (a fluid wave) is utilized to create tissue plane separation as opposed to needle mechanical debridement.
Osteopathic Manipulative Treatment (OMT)
EXPERIMENTALCLBP Subjects with documented TLF glide impairment will undergo a screening structural examination for somatic dysfunction and then be treated by OMT as based on clinical experience using a principle based protocol. A series of 3 OMT treatment sessions spaced at 2-week intervals. The same procedures will be used in this study as we use in our daily clinical practice. This is a pilot treatment arm, no sham or direct blinding will be utilized. Subjects will be screening using the Area of Greatest Restriction (AGR) protocol as taught by Ed Stiles DO (Textbook of Osteopathic Medicine Ch. 24 by Stiles pp. 265-266). After treating 2-3 areas by this method, the examiner will also screen the Lumbar, Sacrum \& Pelvis by standard Osteopathic Structural Evaluation (standing \& supine/prone). An additional 1-2 areas may be treated. Treatments may include High Velocity, Low Amplitude (HVLA), Low Velocity, High Amplitude, soft tissue, myofascial release and muscle energy manipulation techniques.
Interventions
The injection of a fluid solution to separate facial or tissue layers in the body. Usually guided by ultrasound.
The therapeutic application of manually guided forces by an osteopathic physician (US Usage) to improve physiologic function and/or support homeostasis that has been altered by somatic dysfunction. OMT employs a variety of techniques.
Eligibility Criteria
You may qualify if:
- ALL 18-50 year olds with No Low Back Pain (LBP); Acute LBP (\< 3 months); or Chronic LBP (\> 3 months)
You may not qualify if:
- Allergy to ultrasound gel - relative, consider alternatives
- BMI: \> 30
- Pregnancy or Breastfeeding: current or remote, within the past 6 months
- Spinal Surgery: history of lower thoracic or lumbar spine: within the past year, of more than a single level of hardware. (prior single level microdiscectomy, laminectomy, or fusion, that is stable for 1 year or greater is NOT excluded)
- Current Low Back Pain (LBP) or Injury: severe enough to 1) limits activities of daily living, 2) limits the ability to work to less than an 8-hour day, 3) unable to lie prone with a pillow under their abdomen/pelvis for 30-45 minute intervals
- History of Spinal Pathology: ankylosing spondylitis, rheumatoid arthritis or other rheumatic diseases, spinal tumor, or spinal infection
- Corticosteroids: Injections into the low back or systemic medication within the last 3 months. Must be able to cease injections and/or corticosteroid medication during the study
- Medication Usage that cannot be discontinued for length study: anticoagulants, muscle relaxants
- Physical or Manual Therapy Interventions: in the last 90 days: physical therapy, acupuncture or trigger point therapy, any type of manual medicine or other bodywork treatments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Edward Via College of Osteopathic Medicine
Blacksburg, Virginia, 24060, United States
Related Publications (1)
Langevin HM, Fox JR, Koptiuch C, Badger GJ, Greenan-Naumann AC, Bouffard NA, Konofagou EE, Lee WN, Triano JJ, Henry SM. Reduced thoracolumbar fascia shear strain in human chronic low back pain. BMC Musculoskelet Disord. 2011 Sep 19;12:203. doi: 10.1186/1471-2474-12-203.
PMID: 21929806BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gunnar Brolinson DO, FAOASM
Edward Via Colege of Osteopathic Medicine
- PRINCIPAL INVESTIGATOR
Albert J Kozar DO, FAOASM, R-MSK
Edward Via College of Osteopathic Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Osteopathic Manipulative Medicine (OMM), Department of Sports Medicine
Study Record Dates
First Submitted
October 28, 2024
First Posted
February 10, 2025
Study Start
September 1, 2023
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 13, 2026
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share